Sharyn D. Baker

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study”.

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3867

N/A

1.0DataRank · unranked

26 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

A new genomic framework to categorize pediatric acute myeloid leukemia

Nature Genetics(2024)10.1038/s41588-023-01640-3

N/A

0.716DataRank · unranked

117 citations

Jing Ma, Tamara Westover, Yonghui Ni, Guangchun Song, Jamie L. Maciaszek +18 more

BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors

Blood Advances(2022)10.1182/bloodadvances.2022007952

N/A

0.675DataRank · unranked

16 citations

Bhavana Bhatnagar, Shelley Orwick, Jae Yoon Jeon, Eric D. Eisenmann, Jack C. Stromatt +5 more

DPYD Testing: Time to Put Patient Safety First

Journal of Clinical Oncology(2023)10.1200/jco.22.02364

N/A

0.561DataRank · unranked

41 citations

Susan E. Bates, Gabriel A. Brooks, William L. Dahut, Robert B. Diasio, Wafik S. El‐Deiry +17 more

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition

Kidney International(2021)10.1016/j.kint.2021.08.022

N/A

0.515DataRank · unranked

30 citations

JY Kim, Bijay Bisunke, Laura A. Jayne, Josie A. Silvaroli, Michael S. Balzer +12 more

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers(2022)10.3390/cancers15010029

N/A

0.489DataRank · unranked

10 citations

Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick +8 more

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021005614

N/A

0.471DataRank · unranked

11 citations

Jae Yoon Jeon, Zahra Talebi, Daelynn R. Buelow, Josie A. Silvaroli, Moray J. Campbell +4 more

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy

JCI Insight(2023)10.1172/jci.insight.164646

N/A

0.416DataRank · unranked

15 citations

Thomas Drabison, Mahesh R. Nepal, Richard H. Ho, Alix F. Leblanc, Alice A. Gibson +20 more

Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS method

Journal of Chromatography B(2022)10.1016/j.jchromb.2022.123437

N/A

0.360DataRank · unranked

10 citations

Yang Li, Eric D. Eisenmann, William D. Figg, Sharyn D. Baker, Alex Sparreboom +2 more

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0332

N/A

0.345DataRank · unranked

9 citations

Mike Boeckman, Yan Yang, Kevin M. Huang, Peter de Bruijn, Mahesh R. Nepal +11 more

Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis

Research Square(2023)10.21203/rs.3.rs-2925426/v1

N/A

0.241DataRank · unranked

4 citations

Jing Ma, Tamara Westover, Yonghui Ni, Guangchun Song, Jamie L. Maciaszek +16 more

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091

N/A

0.216DataRank · unranked

3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS/MS method for murine plasma analysis

Journal of Chromatography B(2024)10.1016/j.jchromb.2024.124209

N/A

0DataRank · unranked

0 citations

Thomas Drabison, Yan Jin, Eric D. Eisenmann, Alex Sparreboom, Rajgopal Govindarajan +3 more

Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies

Leukemia(2025)10.1038/s41375-024-02498-y

N/A

0DataRank · unranked

4 citations

Deedra Nicolet, Najla Alotaibi, Daelynn R. Buelow, Shelley Orwick, Charles T. Gregory +15 more

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0265

N/A

0DataRank · unranked

1 citations

Eman Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley Orwick +6 more

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia

Clinical and Translational Science(2020)10.1111/cts.12861

N/A

0DataRank · unranked

26 citations

Jason T. Anderson, Stanley Pounds, Lei Shi, Jatinder K. Lamba, Shuiying Hu +5 more

Drug–drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors

Expert Review of Clinical Pharmacology(2025)10.1080/17512433.2025.2606258

N/A

0DataRank · unranked

0 citations

Anika T. Chowdhury, Kevin M. Huang, Shuiying Hu, Alex Sparreboom, Sharyn D. Baker +2 more

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors

Pharmaceutics(2020)10.3390/pharmaceutics12090856

N/A

0DataRank · unranked

48 citations

Zahra Talebi, Eric D. Eisenmann, Alex Sparreboom, Sharyn D. Baker, Dominique A. Garrison

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia

Journal of Hematology & Oncology(2020)10.1186/s13045-019-0821-7

N/A

0DataRank · unranked

20 citations

Abeera Mehmood, Jae Yoon Jeon, Bridget Carmichael, Amy Lehman, Shelley Orwick +13 more

Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0071

N/A

0DataRank · unranked

45 citations

Xiyuan Lu, Zahra Talebi, Jae Yoon Jeon, Daelynn R. Buelow, Alice A. Gibson +13 more

Development, validation, and application of an LC-MS/MS method for the determination of the AXL/FLT3 inhibitor gilteritinib in mouse plasma

Journal of Chromatography B(2021)10.1016/j.jchromb.2021.122882

N/A

0DataRank · unranked

6 citations

Yan Jin, Muhammad Erfan Uddin, Alex Sparreboom, Sharyn D. Baker, Dominique A. Garrison

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

Molecules(2022)10.3390/molecules27206815

N/A

0DataRank · unranked

10 citations

Yan Jin, Zahra Talebi, Shuiying Hu, Alex Sparreboom, Sharyn D. Baker +2 more

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities

Pharmaceutics(2022)10.3390/pharmaceutics14091933

N/A

0DataRank · unranked

7 citations

Yan Jin, Hanieh Taheri, Keith T. Schmidt, Alice A. Gibson, Stefan A.J. Buck +7 more

Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice

Drug Metabolism and Disposition(2023)10.1124/dmd.123.001466

N/A

0DataRank · unranked

8 citations

Yasuhiro Kazuki, Thomas Drabison, Kaoru Kobayashi, Ken‐ichi Fujita, Yue Xu +9 more

Determination and disposition of meta-iodobenzylguanidine in plasma and heart of transporter-deficient mice by UPLC-MS/MS

Journal of Chromatography B(2023)10.1016/j.jchromb.2023.123699

N/A

0DataRank · unranked

2 citations

Yan Jin, Sharyn D. Baker, Daniel Addison, Alex Sparreboom, Zahra Talebi

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

Blood Advances(2023)10.1182/bloodadvances.2023010482

N/A

0DataRank · unranked

2 citations

Jessica Kohlschmidt, Shelley Orwick, Daelynn R. Buelow, Sydney Fobare, Christopher C. Oakes +12 more

Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

(2023)10.1158/1078-0432.c.6532472

N/A

0DataRank · unranked

0 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia

JCI Insight(2024)10.1172/jci.insight.173646

N/A

0DataRank · unranked

6 citations

Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C. Vroom, Mariah L. Johnson +28 more